Megan M. Ullman

483 total citations
25 papers, 371 citations indexed

About

Megan M. Ullman is a scholar working on Hematology, Genetics and Speech and Hearing. According to data from OpenAlex, Megan M. Ullman has authored 25 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 6 papers in Genetics and 2 papers in Speech and Hearing. Recurrent topics in Megan M. Ullman's work include Hemophilia Treatment and Research (21 papers), Platelet Disorders and Treatments (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Megan M. Ullman is often cited by papers focused on Hemophilia Treatment and Research (21 papers), Platelet Disorders and Treatments (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Megan M. Ullman collaborates with scholars based in United States, Canada and Russia. Megan M. Ullman's co-authors include Randall Curtis, Brenda Riske, Judith Baker, Michael B. Nichol, Marion A. Koerper, Jiat Ling Poon, W. Keith Hoots, Kathleen A. Johnson, Mimi Lou and Zheng‐Yi Zhou and has published in prestigious journals such as Blood, American Journal of Preventive Medicine and American Journal of Hematology.

In The Last Decade

Megan M. Ullman

23 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Megan M. Ullman United States 9 331 48 30 24 17 25 371
J. Sek Canada 7 383 1.2× 90 1.9× 34 1.1× 27 1.1× 17 1.0× 7 461
Natalie Duncan United States 11 493 1.5× 110 2.3× 39 1.3× 25 1.0× 4 0.2× 17 532
L. H. Schrijvers Netherlands 9 264 0.8× 42 0.9× 8 0.3× 37 1.5× 5 0.3× 15 309
Liz Carroll United Kingdom 7 292 0.9× 38 0.8× 26 0.9× 3 0.1× 17 1.0× 11 332
A Miners United Kingdom 9 258 0.8× 51 1.1× 28 0.9× 10 0.4× 16 0.9× 12 367
Pacharapan Surapolchai Thailand 7 71 0.2× 103 2.1× 19 0.6× 10 0.4× 7 0.4× 18 170
Jeanette Payne United Kingdom 8 137 0.4× 34 0.7× 14 0.5× 5 0.2× 8 0.5× 17 186
Andrea Di Palma Italy 10 149 0.5× 140 2.9× 53 1.8× 3 0.1× 13 0.8× 20 248
Ramya Ramanujachar United Kingdom 5 97 0.3× 20 0.4× 26 0.9× 87 3.6× 6 0.4× 9 319
Corien L. Eckhardt Netherlands 12 331 1.0× 78 1.6× 83 2.8× 2 0.1× 13 0.8× 23 399

Countries citing papers authored by Megan M. Ullman

Since Specialization
Citations

This map shows the geographic impact of Megan M. Ullman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan M. Ullman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan M. Ullman more than expected).

Fields of papers citing papers by Megan M. Ullman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan M. Ullman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan M. Ullman. The network helps show where Megan M. Ullman may publish in the future.

Co-authorship network of co-authors of Megan M. Ullman

This figure shows the co-authorship network connecting the top 25 collaborators of Megan M. Ullman. A scholar is included among the top collaborators of Megan M. Ullman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan M. Ullman. Megan M. Ullman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lanzkron, Sophie, Joanne Wu, Randall Curtis, et al.. (2024). Costs and impact of disease in adults with sickle cell disease: a pilot study. Blood Advances. 8(14). 3629–3638. 4 indexed citations
2.
Curtis, Randall, Jonathan Roberts, Judith Baker, et al.. (2023). Trends in prescribing practices for management of haemophilia: 1999–2021. Haemophilia. 29(3). 761–769. 2 indexed citations
3.
Tran, Duc Quang, Megan M. Ullman, Brenda Riske, et al.. (2023). Adherence to Clotting Factor Treatment and Association with Bleeding and Health-Related Quality of Life in Persons with Hemophilia. Blood. 142(Supplement 1). 7334–7334. 1 indexed citations
4.
Curtis, Randall, Marilyn J. Manco‐Johnson, Barbara A. Konkle, et al.. (2022). Comorbidities, Health-Related Quality of Life, Health-care Utilization in Older Persons with Hemophilia—Hematology Utilization Group Study Part VII (HUGS VII). Journal of Blood Medicine. Volume 13. 229–241. 8 indexed citations
5.
Roberts, Jonathan, Roshni Kulkarni, Peter A. Kouides, et al.. (2021). Depression and Anxiety in Persons with Von Willebrand Disease. Blood. 138(Supplement 1). 4052–4052. 4 indexed citations
6.
Lanzkron, Sophie, Joanne Wu, Randall Curtis, et al.. (2021). PRO66 Health-Related Quality of Life in Persons with Sickle Cell Disease. Value in Health. 24. S209–S210. 1 indexed citations
7.
Wu, Joanne, Randall Curtis, Megan M. Ullman, et al.. (2020). Depressive Disorders Among Adults with Hemophilia a. Blood. 136(Supplement 1). 32–32.
8.
Ullman, Megan M., Randall Curtis, Mimi Lou, et al.. (2019). Is Hemophilia B Clinically Less Severe Than Hemophilia a? Evidence from the Hugs Va and Vb Studies. Blood. 134(Supplement_1). 58–58. 1 indexed citations
9.
Nichol, Michael B., Yaping Xu, Judith Baker, et al.. (2017). Health-Related Quality of Life and Health Insurance Coverage Among Persons with Hemophilia A Inhibitors. Blood. 130. 4736–4736. 1 indexed citations
10.
Ullman, Megan M., et al.. (2017). Prophylaxis use among males with haemophilia B in the United States. Haemophilia. 23(6). 910–917. 8 indexed citations
11.
Zhou, Zheng‐Yi, Marion A. Koerper, Kathleen A. Johnson, et al.. (2015). Burden of illness: direct and indirect costs among persons with hemophilia A in the United States. Journal of Medical Economics. 18(6). 457–465. 104 indexed citations
12.
Adams, Elizabeth, et al.. (2014). An inventory of healthy weight practices in federally funded haemophilia treatment centres in the United States. Haemophilia. 20(5). 639–643. 6 indexed citations
13.
Poon, Jiat Ling, Jason N. Doctor, Femida Gwadry‐Sridhar, et al.. (2013). Longitudinal changes in health-related quality of life for chronic diseases: An example from the hemophilia utilization group study part va (HUGS Va). Value in Health. 16(3). A122–A123. 1 indexed citations
14.
Ullman, Megan M., et al.. (2013). Association of overweight and obesity with the use of self and home‐based infusion therapy among haemophilic men. Haemophilia. 20(3). 340–348. 10 indexed citations
15.
Poon, Jiat Ling, Zhongmei Zhou, Jason N. Doctor, et al.. (2012). Quality of life in haemophilia A: Hemophilia Utilization Group Study Va (HUGS‐Va). Haemophilia. 18(5). 699–707. 58 indexed citations
16.
Poon, Jiat Ling, et al.. (2011). PND47 THE HEMOPHILIA UTILIZATION GROUP STUDY (HUGS-VB): HEALTH-RELATED QUALITY OF LIFE IN HEMOPHILIA B. Value in Health. 14(3). A210–A210. 3 indexed citations
17.
Zhou, Zheng‐Yi, Brenda Riske, Ann D. Forsberg, et al.. (2011). Self-Reported Barriers to Hemophilia Care in People with Factor VIII Deficiency. American Journal of Preventive Medicine. 41(6). S346–S353. 19 indexed citations
18.
Zhou, Zhongmei, Joanne Wu, Judith Baker, et al.. (2011). Haemophilia Utilization Group Study – Part Va (HUGS Va): design, methods and baseline data. Haemophilia. 17(5). 729–736. 25 indexed citations
19.
Gwadry‐Sridhar, Femida, et al.. (2011). PND33 UTILIZING A PAPER STANDARD GAMBLE INSTRUMENT TO ASSESS HEALTH UTILITY IN PATIENTS WITH HEMOPHILIA B. Value in Health. 14(3). A208–A208.
20.
Ullman, Megan M. & W. Keith Hoots. (2006). Assessing the costs for clinical care of patients with high‐responding factor VIII and IX inhibitors. Haemophilia. 12(s6). 74–80. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Sek Breakdown of academic impact, for papers by Natalie Duncan Breakdown of academic impact, for papers by L. H. Schrijvers Breakdown of academic impact, for papers by Liz Carroll Breakdown of academic impact, for papers by A Miners Breakdown of academic impact, for papers by Pacharapan Surapolchai Breakdown of academic impact, for papers by Jeanette Payne Breakdown of academic impact, for papers by Andrea Di Palma Breakdown of academic impact, for papers by Ramya Ramanujachar Breakdown of academic impact, for papers by Corien L. Eckhardt
Rankless by CCL
2026